Since arriving on the market in 2011, the Ion Torrent PGM, a benchtop sequencer, has already been successfully used for the targeted resequencing of cancer genes, such as BRCA[15], BRAF[14], POLE and POLD1[13]. This evidence concerns the gene POLD1 and cancer.